Malachite Innovations, Inc. VBIO OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

35/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Malachite Innovations, Inc. (VBIO) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 32/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

35/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

25/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — VBIO

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.02

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2012	$-0.26	$0.00	$-1.32M	-
2013	$-0.51	$0.00	$-2.74M	-
2014	$-0.69	$0.00	$-4.15M	-
2015	$-0.57	$245.68K	$-4.05M	-1647.8%
2016	$-0.02	$248.35K	$-141.33K	-56.9%
2017	$-0.38	$163.36K	$-5.22M	-3195%
2018	$-0.19	$102.42K	$-4.31M	-4207.2%
2019	$-0.61	$0.00	$-20.14M	-
2020	$-0.09	$0.00	$-4.37M	-
2021	$-0.02	$0.00	$-880.85K	-